Close Menu

NEW YORK (GenomeWeb) – French diagnostics firm Novacyt said today that it has entered into a €4 million ($4.7 million) unsecured debt facility with an undisclosed institutional investor.

Novacyt said that it would use the proceeds of the facility to support its merger and acquisition strategy, and that it currently has negotiations underway for potential deals with multiple profitable clinical diagnostics companies.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by
LGC SeraCare Life Sciences

Non-invasive prenatal testing (NIPT) continues to expand globally to support maternal-fetal patient care. 

Sponsored by

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.